ArticleCancers2023

Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study.

Anna Astarita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.